{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:44:06Z","timestamp":1793339046437,"version":"4.5.0"},"reference-count":164,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Cardiovascular disease (CVD) frequently occurs in patients with chronic kidney disease (CKD), particularly those undergoing dialysis. The mechanisms behind this may be related to traditional risk factors and CKD-specific factors that accelerate atherosclerosis and vascular calcification in CKD patients. The accumulation of uremic toxins is a significant factor in CKD-related systemic disorders. Basic research suggests that indoxyl sulfate (IS), a small protein-bound uremic toxin, is associated with macrophage dysfunctions, including increased oxidative stress, exacerbation of chronic inflammation, and abnormalities in lipid metabolism. Strategies to mitigate the toxicity of IS include optimizing gut microbiota, intervening against the abnormality of intracellular signal transduction, and using blood purification therapy with higher efficiency. Further research is needed to examine whether lowering protein-bound uremic toxins through intervention leads to a reduction in CVD in patients with CKD.<\/jats:p>","DOI":"10.3390\/toxins16060254","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T03:46:49Z","timestamp":1717127209000},"page":"254","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Indoxyl Sulfate-Induced Macrophage Toxicity and Therapeutic Strategies in Uremic Atherosclerosis"],"prefix":"10.3390","volume":"16","author":[{"given":"Takuya","family":"Wakamatsu","sequence":"first","affiliation":[{"name":"Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan"},{"name":"Ohgo Clinic, Maebashi 371-0232, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8279-2966","authenticated-orcid":false,"given":"Suguru","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiei","family":"Narita","sequence":"additional","affiliation":[{"name":"Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/gerona\/62.8.879","article-title":"Efficacy and safety of statin monotherapy in older adults: A meta-analysis","volume":"62","author":"Roberts","year":"2007","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis","volume":"360","author":"Jardine","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrneph.2010.143","article-title":"Atherosclerosis in CKD: Differences from the general population","volume":"6","author":"Massy","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.HYP.0000167121.14254.a0","article-title":"Kidney in early atherosclerosis","volume":"45","author":"Chade","year":"2005","journal-title":"Hypertension"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrneph.2010.157","article-title":"Atherosclerosis in chronic kidney disease: The role of macrophages","volume":"7","author":"Kon","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Haarhaus, M., Cianciolo, G., Barbuto, S., La Manna, G., Gasperoni, L., Tripepi, G., Plebani, M., Fusaro, M., and Magnusson, P. (2022). Alkaline Phosphatase: An Old Friend as Treatment Target for Cardiovascular and Mineral Bone Disorders in Chronic Kidney Disease. Nutrients, 14.","DOI":"10.3390\/nu14102124"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1681\/ASN.2020050598","article-title":"Optimal Phosphate Control Related to Coronary Artery Calcification in Dialysis Patients","volume":"32","author":"Isaka","year":"2021","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2215\/CJN.12620921","article-title":"Association of Serum Phosphate with Efficacy of Statin Therapy in Hemodialysis Patients","volume":"17","author":"Massy","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(22)02074-8","article-title":"Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: Collaborative meta-analysis of large placebo-controlled trials","volume":"400","author":"Baigent","year":"2022","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJMoa2304820","article-title":"Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure","volume":"389","author":"Blankestijn","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_16","first-page":"298","article-title":"Cause-specific excess mortality among dialysis patients: Comparison with the general population in Japan","volume":"17","author":"Wakasugi","year":"2013","journal-title":"Ther. Apher. Dial. Off. Peer-Rev. J. Int. Soc. Apher. Jpn. Soc. Apher. Jpn. Soc. Dial. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Lin, C.J., Wu, V., Wu, P.C., and Wu, C.J. (2015). Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132589"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/039139880102401004","article-title":"Uremic toxicity: Present state of the art","volume":"24","author":"Vanholder","year":"2001","journal-title":"Int. J. Artif. Organs"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1046\/j.1523-1755.63.s84.43.x","article-title":"New insights in uremic toxins","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int. Suppl."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.2215\/CJN.02660221","article-title":"Classification of Uremic Toxins and Their Role in Kidney Failure","volume":"16","author":"Rosner","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"ref_21","first-page":"1892","article-title":"Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats","volume":"23","author":"Adijiang","year":"2008","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc.-Eur. Ren. Assoc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e00092","DOI":"10.1002\/prp2.92","article-title":"p-Cresyl sulfate, a uremic toxin, causes vascular endothelial and smooth muscle cell damages by inducing oxidative stress","volume":"3","author":"Watanabe","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/ckj\/sfaa121","article-title":"Serum total indoxyl sulfate and clinical outcomes in hemodialysis patients: Results from the Japan Dialysis Outcomes and Practice Patterns Study","volume":"14","author":"Yamamoto","year":"2021","journal-title":"Clin. Kidney J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.ki.5000115","article-title":"Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients","volume":"69","author":"Bammens","year":"2006","journal-title":"Kidney Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s00216-012-5929-3","article-title":"Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography\/tandem mass spectrometry and their effects on endothelial ROS production","volume":"403","author":"Itoh","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neuro.2016.01.006","article-title":"Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease","volume":"53","author":"Yeh","year":"2016","journal-title":"Neurotoxicology"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Vanholder, R., Van Laecke, S., Glorieux, G., Verbeke, F., Castillo-Rodriguez, E., and Ortiz, A. (2018). Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD). Toxins, 10.","DOI":"10.3390\/toxins10060237"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.ki.5002097","article-title":"Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells","volume":"71","author":"Iwasaki","year":"2007","journal-title":"Kidney Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cca.2018.05.057","article-title":"Effect of uremic toxin-indoxyl sulfate on the skeletal system","volume":"484","author":"Liu","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kim, Y.H., Kwak, K.A., Gil, H.W., Song, H.Y., and Hong, S.Y. (2013). Indoxyl sulfate promotes apoptosis in cultured osteoblast cells. BMC Pharmacol. Toxicol., 14.","DOI":"10.1186\/2050-6511-14-60"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1038\/s41598-024-53164-3","article-title":"Dose-dependent exposure to indoxyl sulfate alters AHR signaling, sirtuins gene expression, oxidative DNA damage, and bone mineral status in rats","volume":"14","author":"Karbowska","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Shyu, J.F., Liu, W.C., Zheng, C.M., Fang, T.C., Hou, Y.C., Chang, C.T., Liao, T.Y., Chen, Y.C., and Lu, K.C. (2021). Toxic Effects of Indoxyl Sulfate on Osteoclastogenesis and Osteoblastogenesis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222011265"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"32084","DOI":"10.1038\/srep32084","article-title":"Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1","volume":"6","author":"Enoki","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"36618","DOI":"10.1038\/srep36618","article-title":"Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease","volume":"6","author":"Sato","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_36","first-page":"11532","article-title":"Indoxyl sulfate induced frailty in patients with end-stage renal disease by disrupting the PGC-1\u03b1-FNDC5 axis","volume":"15","author":"Hou","year":"2023","journal-title":"Aging"},{"key":"ref_37","first-page":"103","article-title":"Indoxyl sulfate inhibits muscle cell differentiation via Myf6\/MRF4 and MYH2 downregulation","volume":"39","author":"Bataille","year":"2023","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc.-Eur. Ren. Assoc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1023383","DOI":"10.3389\/fmed.2023.1023383","article-title":"Indoxyl sulfate mediates low handgrip strength and is predictive of high hospitalization rates in patients with end-stage renal disease","volume":"10","author":"Hou","year":"2023","journal-title":"Front. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Lee, S.M., Han, M.Y., Kim, S.H., Cha, R.H., Kang, S.H., Kim, J.C., and An, W.S. (2022). Indoxyl Sulfate Might Play a Role in Sarcopenia, While Myostatin Is an Indicator of Muscle Mass in Patients with Chronic Kidney Disease: Analysis from the RECOVERY Study. Toxins, 14.","DOI":"10.3390\/toxins14100660"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"9130","DOI":"10.1038\/s41598-021-88438-7","article-title":"\u03b22-adrenergic receptor agonist counteracts skeletal muscle atrophy and oxidative stress in uremic mice","volume":"11","author":"Higashihara","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00223-020-00719-x","article-title":"Association of Serum Indoxyl Sulfate Levels with Skeletal Muscle Mass and Strength in Chronic Hemodialysis Patients: A 2-year Longitudinal Analysis","volume":"107","author":"Lin","year":"2020","journal-title":"Calcif. Tissue Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"C701","DOI":"10.1152\/ajpcell.00098.2019","article-title":"Uremic metabolites impair skeletal muscle mitochondrial energetics through disruption of the electron transport system and matrix dehydrogenase activity","volume":"317","author":"Thome","year":"2019","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cbi.2019.02.023","article-title":"Indoxyl sulfate induces myotube atrophy by ROS-ERK and JNK-MAFbx cascades","volume":"304","author":"Changchien","year":"2019","journal-title":"Chem.-Biol. Interact."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/jcsm.12202","article-title":"Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction","volume":"8","author":"Enoki","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e145475","DOI":"10.1172\/jci.insight.145475","article-title":"Indoxyl sulfate reduces Ito, f by activating ROS\/MAPK and NF-\u03baB signaling pathways","volume":"7","author":"Yang","year":"2022","journal-title":"JCI Insight"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12012-021-09718-2","article-title":"Indoxyl Sulfate Activates NLRP3 Inflammasome to Induce Cardiac Contractile Dysfunction Accompanied by Myocardial Fibrosis and Hypertrophy","volume":"22","author":"Yamaguchi","year":"2022","journal-title":"Cardiovasc. Toxicol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Changchien, C.Y., Sung, M.H., Chang, H.H., Tsai, W.C., Peng, Y.S., and Chen, Y. (2020). Uremic toxin indoxyl sulfate suppresses myocardial Cx43 assembly and expression via JNK activation. Chem.-Biol. Interact., 319.","DOI":"10.1016\/j.cbi.2020.108979"},{"key":"ref_48","first-page":"5117","article-title":"Endoplasmic reticulum stress associated apoptosis as a novel mechanism in indoxyl sulfate-induced cardiomyocyte toxicity","volume":"18","author":"Tan","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Tang, W.H., Wang, C.P., Chung, F.M., Huang, L.L., Yu, T.H., Hung, W.C., Lu, L.F., Chen, P.Y., Luo, C.H., and Lee, K.T. (2015). Uremic retention solute indoxyl sulfate level is associated with prolonged QTc interval in early CKD patients. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0119545"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.toxlet.2015.01.021","article-title":"Indoxyl sulfate induces oxidative stress and hypertrophy in cardiomyocytes by inhibiting the AMPK\/UCP2 signaling pathway","volume":"234","author":"Yang","year":"2015","journal-title":"Toxicol. Lett."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/eurheartj\/ehp574","article-title":"Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?","volume":"31","author":"Lekawanvijit","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1083\/jcb.201412052","article-title":"Recent insights into the cellular biology of atherosclerosis","volume":"209","author":"Tabas","year":"2015","journal-title":"J. Cell Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/nm.3258","article-title":"Local proliferation dominates lesional macrophage accumulation in atherosclerosis","volume":"19","author":"Robbins","year":"2013","journal-title":"Nat. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/ATVBAHA.119.312802","article-title":"Macrophages in Atherosclerosis Regression","volume":"40","author":"Barrett","year":"2020","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ki.2012.345","article-title":"Chronic kidney disease alters intestinal microbial flora","volume":"83","author":"Vaziri","year":"2013","journal-title":"Kidney Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.chom.2016.10.021","article-title":"Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota","volume":"20","author":"Devlin","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"38869","DOI":"10.1074\/jbc.M110.166686","article-title":"Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin","volume":"285","author":"Ito","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s12276-022-00738-8","article-title":"Indoxyl sulfate- and P-cresol-induced monocyte adhesion and migration is mediated by integrin-linked kinase-dependent podosome formation","volume":"54","author":"Campillo","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.mam.2012.10.009","article-title":"The SLCO (former SLC21) superfamily of transporters","volume":"34","author":"Hagenbuch","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1152\/physrev.00025.2013","article-title":"The organic anion transporter (OAT) family: A systems biology perspective","volume":"95","author":"Nigam","year":"2015","journal-title":"Physiol. Rev."},{"key":"ref_63","first-page":"2051","article-title":"Indoxyl sulphate induces oxidative stress and the expression of osteoblast-specific proteins in vascular smooth muscle cells","volume":"24","author":"Muteliefu","year":"2009","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc.-Eur. Ren. Assoc."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000365217","article-title":"Indoxyl sulfate induces IL-6 expression in vascular endothelial and smooth muscle cells through OAT3-mediated uptake and activation of AhR\/NF-\u03baB pathway","volume":"128","author":"Adelibieke","year":"2014","journal-title":"Nephron. Exp. Nephrol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.lfs.2012.01.013","article-title":"Indoxyl sulfate upregulates renal expression of MCP-1 via production of ROS and activation of NF-\u03baB, p53, ERK, and JNK in proximal tubular cells","volume":"90","author":"Shimizu","year":"2012","journal-title":"Life Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/CIRCULATIONAHA.118.034588","article-title":"Uremic Toxin Indoxyl Sulfate Promotes Proinflammatory Macrophage Activation Via the Interplay of OATP2B1 and Dll4-Notch Signaling","volume":"139","author":"Nakano","year":"2019","journal-title":"Circulation"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/09168451.2020.1715782","article-title":"Investigation of the effects of indoxyl sulfate, a uremic toxin, on the intracellular oxidation level and phagocytic activity using an HL-60-differentiated human macrophage cell model","volume":"84","author":"Tsutsumi","year":"2020","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ancuta","year":"2010","journal-title":"Blood"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1093\/cvr\/cvad069","article-title":"Monocyte heterogeneity in cardiovascular disease","volume":"119","author":"Ruder","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/eurheartj\/ehq371","article-title":"CD14+ + CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease","volume":"32","author":"Rogacev","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/sji.12314","article-title":"The Role of Different Monocyte Subsets in the Pathogenesis of Atherosclerosis and Acute Coronary Syndromes","volume":"82","author":"Idzkowska","year":"2015","journal-title":"Scand. J. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Barisione, C., Garibaldi, S., Furfaro, A.L., Nitti, M., Palmieri, D., Passalacqua, M., Garuti, A., Verzola, D., Parodi, A., and Ameri, P. (2016). Moderate Increase of Indoxyl Sulfate Promotes Monocyte Transition into Profibrotic Macrophages. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149276"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: Mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Atri, C., Guerfali, F.Z., and Laouini, D. (2018). Role of Human Macrophage Polarization in Inflammation during Infectious Diseases. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19061801"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Adesso, S., Popolo, A., Bianco, G., Sorrentino, R., Pinto, A., Autore, G., and Marzocco, S. (2013). The uremic toxin indoxyl sulphate enhances macrophage response to LPS. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076778"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1189\/jlb.0112023","article-title":"Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease","volume":"93","author":"Ito","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Bolati, D., Shimizu, H., Yisireyili, M., Nishijima, F., and Niwa, T. (2013). Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-\u03baB. BMC Nephrol., 14.","DOI":"10.1186\/1471-2369-14-56"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1681\/ASN.2017040391","article-title":"Wnt\/\u03b2-Catenin-Promoted Macrophage Alternative Activation Contributes to Kidney Fibrosis","volume":"29","author":"Feng","year":"2018","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2016-10-744060","article-title":"Indoxyl sulfate induces platelet hyperactivity and contributes to chronic kidney disease-associated thrombosis in mice","volume":"129","author":"Yang","year":"2017","journal-title":"Blood"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"9139","DOI":"10.18632\/aging.103183","article-title":"Klotho alleviates indoxyl sulfate-induced heart failure and kidney damage by promoting M2 macrophage polarization","volume":"12","author":"Lv","year":"2020","journal-title":"Aging"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease","volume":"22","author":"Hu","year":"2011","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"116570","DOI":"10.1016\/j.lfs.2019.116570","article-title":"Klotho restrain RIG-1\/NF-\u03baB signaling activation and monocyte inflammatory factor release under uremic condition","volume":"231","author":"He","year":"2019","journal-title":"Life Sci."},{"key":"ref_84","first-page":"125","article-title":"Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease","volume":"15","author":"Fujii","year":"2011","journal-title":"Ther. Apher. Dial. Off. Peer-Rev. J. Int. Soc. Apher. Jpn. Soc. Apher. Jpn. Soc. Dial. Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.3390\/toxins7083155","article-title":"Increased Proinflammatory Cytokine Production and Decreased Cholesterol Efflux Due to Downregulation of ABCG1 in Macrophages Exposed to Indoxyl Sulfate","volume":"7","author":"Matsuo","year":"2015","journal-title":"Toxins"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"960","DOI":"10.5551\/jat.34462","article-title":"Crucial Role of the Aryl Hydrocarbon Receptor (AhR) in Indoxyl Sulfate-Induced Vascular Inflammation","volume":"23","author":"Ito","year":"2016","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Tanaka, M., Fujikawa, M., Oguro, A., Itoh, K., Vogel, C.F.A., and Ishihara, Y. (2021). Involvement of the Microglial Aryl Hydrocarbon Receptor in Neuroinflammation and Vasogenic Edema after Ischemic Stroke. Cells, 10.","DOI":"10.3390\/cells10040718"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.molmed.2004.09.003","article-title":"Nrf2-Keap1 defines a physiologically important stress response mechanism","volume":"10","author":"Motohashi","year":"2004","journal-title":"Trends Mol. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.biochi.2012.07.015","article-title":"Nrf2-keap1 system versus NF-\u03baB: The good and the evil in chronic kidney disease?","volume":"94","author":"Pedruzzi","year":"2012","journal-title":"Biochimie"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"F662","DOI":"10.1152\/ajprenal.00421.2009","article-title":"Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure","volume":"298","author":"Kim","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bcp.2018.07.039","article-title":"Cardamonin, a natural flavone, alleviates inflammatory bowel disease by the inhibition of NLRP3 inflammasome activation via an AhR\/Nrf2\/NQO1 pathway","volume":"155","author":"Wang","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"ref_92","first-page":"286","article-title":"Indoxyl sulfate and p-cresyl sulfate in chronic kidney disease. Could these toxins modulate the antioxidant Nrf2-Keap1 pathway?","volume":"24","author":"Fouque","year":"2014","journal-title":"J. Ren. Nutr. Off. J. Counc. Ren. Nutr. Natl. Kidney Found."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Wakamatsu, T., Yamamoto, S., Ito, T., Sato, Y., Matsuo, K., Takahashi, Y., Kaneko, Y., Goto, S., Kazama, J.J., and Gejyo, F. (2018). Indoxyl Sulfate Promotes Macrophage IL-1\u03b2 Production by Activating Aryl Hydrocarbon Receptor\/NF-\u03ba\/MAPK Cascades, but the NLRP3 inflammasome Was Not Activated. Toxins, 10.","DOI":"10.3390\/toxins10030124"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Ho, L.C., Wu, T.Y., Lin, T.M., Liou, H.H., and Hung, S.Y. (2021). Indoxyl Sulfate Mediates the Low Inducibility of the NLRP3 Inflammasome in Hemodialysis Patients. Toxins, 13.","DOI":"10.3390\/toxins13010038"},{"key":"ref_95","first-page":"10844","article-title":"Indoxyl sulfate-induced TNF-\u03b1 is regulated by crosstalk between the aryl hydrocarbon receptor, NF-\u03baB, and SOCS2 in human macrophages","volume":"33","author":"Kim","year":"2019","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nature04517","article-title":"Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin\/Nalp3","volume":"440","author":"Kanneganti","year":"2006","journal-title":"Nature"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature04515","article-title":"Cryopyrin activates the inflammasome in response to toxins and ATP","volume":"440","author":"Mariathasan","year":"2006","journal-title":"Nature"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00109-017-1575-8","article-title":"Mechanisms of foam cell formation in atherosclerosis","volume":"95","author":"Chistiakov","year":"2017","journal-title":"J. Mol. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"11811","DOI":"10.1016\/S0021-9258(19)50272-1","article-title":"CD36 is a receptor for oxidized low density lipoprotein","volume":"268","author":"Endemann","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jab.2014.07.001","article-title":"Indoxyl sulfate stimulates oxidized LDL uptake through up-regulation of CD36 expression in THP-1 macrophages","volume":"12","author":"Cao","year":"2014","journal-title":"J. Appl. Biomed."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbrc.2012.07.011","article-title":"Oxidized low-density lipoprotein induces secretion of interleukin-1\u03b2 by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation","volume":"425","author":"Jiang","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1194\/jlr.S091280","article-title":"Inflammasomes, neutrophil extracellular traps, and cholesterol","volume":"60","author":"Tall","year":"2019","journal-title":"J. Lipid Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000186303","article-title":"Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis","volume":"57","author":"Attman","year":"1991","journal-title":"Nephron"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1159\/000186958","article-title":"Comparison of lipids, apoproteins and associated enzyme activities between diabetic and nondiabetic end-stage renal disease","volume":"61","author":"Sakurai","year":"1992","journal-title":"Nephron"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1080\/0886022X.2020.1845731","article-title":"Indoxyl sulfate and high-density lipoprotein cholesterol in early stages of chronic kidney disease","volume":"42","author":"Wang","year":"2020","journal-title":"Ren. Fail."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s11255-022-03137-0","article-title":"Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein (HDL) ratio (MHR) in chronic kidney disease patients","volume":"54","author":"Cernaro","year":"2022","journal-title":"Int. Urol. Nephrol."},{"key":"ref_108","first-page":"1554","article-title":"Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients","volume":"29","author":"Moradi","year":"2014","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc.-Eur. Ren. Assoc."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12944-021-01546-1","article-title":"Non-high-density lipoprotein cholesterol may predict the cardio-cerebrovascular risk in patients on maintenance hemodialysis","volume":"20","author":"Luo","year":"2021","journal-title":"Lipids Health Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/MOL.0000000000000571","article-title":"HDL modification: Recent developments and their relevance to atherosclerotic cardiovascular disease","volume":"30","author":"Wilkins","year":"2019","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Kudinov, V.A., Alekseeva, O.Y., Torkhovskaya, T.I., Baskaev, K.K., Artyushev, R.I., Saburina, I.N., and Markin, S.S. (2020). High-Density Lipoproteins as Homeostatic Nanoparticles of Blood Plasma. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228737"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.atherosclerosis.2018.09.009","article-title":"Increased electronegativity of high-density lipoprotein in uremia patients impairs its functional properties and is associated with the risk of coronary artery disease","volume":"278","author":"Chang","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.jacc.2012.09.013","article-title":"Dysfunctional high-density lipoprotein in patients on chronic hemodialysis","volume":"60","author":"Yamamoto","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_114","first-page":"731","article-title":"Short-Term Effects of a Therapeutic Diet on Biochemical Parameters in Hemodialysis Patients: A Randomized Crossover Trial","volume":"33","author":"Tsai","year":"2023","journal-title":"J. Ren. Nutr. Off. J. Counc. Ren. Nutr. Natl. Kidney Found."},{"key":"ref_115","first-page":"412","article-title":"The New Nordic Renal Diet Induces a Pronounced Reduction of Urine Acid Excretion and Uremic Toxins in Chronic Kidney Disease Patients (Stage 3 and 4)","volume":"33","author":"Hansen","year":"2023","journal-title":"J. Ren. Nutr. Off. J. Counc. Ren. Nutr. Natl. Kidney Found."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000321848","article-title":"Intestinal-renal syndrome: Mirage or reality?","volume":"31","author":"Ritz","year":"2011","journal-title":"Blood Purif."},{"key":"ref_117","first-page":"401","article-title":"Gut Lactobacillus protects against the progression of renal damage by modulating the gut environment in rats","volume":"31","author":"Yoshifuji","year":"2016","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc.-Eur. Ren. Assoc."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.kint.2017.02.011","article-title":"Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach","volume":"92","author":"Mishima","year":"2017","journal-title":"Kidney Int."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1681\/ASN.2014060530","article-title":"Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD","volume":"26","author":"Mishima","year":"2015","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"F824","DOI":"10.1152\/ajprenal.00314.2017","article-title":"Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model","volume":"315","author":"Mishima","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/CIRCULATIONAHA.123.065517","article-title":"Metabolic Communication by SGLT2 Inhibition","volume":"149","author":"Billing","year":"2024","journal-title":"Circulation"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.bbrc.2020.04.079","article-title":"Metabolomics of a mouse model of preeclampsia induced by overexpressing soluble fms-like tyrosine kinase 1","volume":"527","author":"Sato","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000450619","article-title":"Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease","volume":"135","author":"Kikuchi","year":"2017","journal-title":"Nephron"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s10157-018-1577-z","article-title":"Oral adsorbent AST-120 ameliorates gut environment and protects against the progression of renal impairment in CKD rats","volume":"22","author":"Yoshifuji","year":"2018","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.kint.2022.06.025","article-title":"The impact of dietary nutrient intake on gut microbiota in the progression and complications of chronic kidney disease","volume":"102","author":"Koppe","year":"2022","journal-title":"Kidney Int."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000346628","article-title":"Very low protein diet reduces indoxyl sulfate levels in chronic kidney disease","volume":"35","author":"Marzocco","year":"2013","journal-title":"Blood Purif."},{"key":"ref_127","first-page":"278","article-title":"The impact of synbiotic treatment on the levels of gut-derived uremic toxins, inflammation, and gut microbiome of chronic kidney disease patients- A randomized trial","volume":"33","author":"Svorcan","year":"2022","journal-title":"J. Ren. Nutr. Off. J. Counc. Ren. Nutr. Natl. Kidney Found."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"850425","DOI":"10.3389\/fnut.2022.850425","article-title":"Probiotics, Prebiotics, and Synbiotics Improve Uremic, Inflammatory, and Gastrointestinal Symptoms in End-Stage Renal Disease with Dialysis: A Network Meta-Analysis of Randomized Controlled Trials","volume":"9","author":"Yu","year":"2022","journal-title":"Front. Nutr."},{"key":"ref_129","first-page":"10","article-title":"Biotic Supplements in Patients with Chronic Kidney Disease: Meta-Analysis of Randomized Controlled Trials","volume":"32","author":"Liu","year":"2022","journal-title":"J. Ren. Nutr. Off. J. Counc. Ren. Nutr. Natl. Kidney Found."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Ebrahim, Z., Proost, S., Tito, R.Y., Raes, J., Glorieux, G., Moosa, M.R., and Blaauw, R. (2022). The Effect of \u00df-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial. Nutrients, 14.","DOI":"10.3390\/nu14040805"},{"key":"ref_131","first-page":"542","article-title":"Diet Quality and Protein-Bound Uraemic Toxins: Investigation of Novel Risk Factors and the Role of Microbiome in Chronic Kidney Disease","volume":"32","author":"McFarlane","year":"2022","journal-title":"J. Ren. Nutr. Off. J. Counc. Ren. Nutr. Natl. Kidney Found."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Cosola, C., Rocchetti, M.T., di Bari, I., Acquaviva, P.M., Maranzano, V., Corciulo, S., Di Ciaula, A., Di Palo, D.M., La Forgia, F.M., and Fontana, S. (2021). An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients. Toxins, 13.","DOI":"10.3390\/toxins13050334"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/advances\/nmab149","article-title":"Effects of Microbiota-Driven Therapy on Circulating Indoxyl Sulfate and P-Cresyl Sulfate in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"13","author":"Chen","year":"2022","journal-title":"Adv. Nutr."},{"key":"ref_134","first-page":"209","article-title":"Prebiotic, Probiotic, and Synbiotic Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-analysis","volume":"29","author":"McFarlane","year":"2019","journal-title":"J. Ren. Nutr. Off. J. Counc. Ren. Nutr. Natl. Kidney Found."},{"key":"ref_135","first-page":"1876","article-title":"Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: A randomized controlled trial","volume":"34","author":"Ramos","year":"2019","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc.-Eur. Ren. Assoc."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/0006-2952(76)90421-4","article-title":"Antioxidant activity of curcumin and related compounds","volume":"25","author":"Sharma","year":"1976","journal-title":"Biochem. Pharmacol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"24995","DOI":"10.1074\/jbc.270.42.24995","article-title":"Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]","volume":"270","author":"Singh","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.clnesp.2023.11.015","article-title":"Can curcumin supplementation break the vicious cycle of inflammation, oxidative stress, and uremia in patients undergoing peritoneal dialysis?","volume":"59","author":"Reis","year":"2024","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1016\/j.clnu.2020.03.007","article-title":"Impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients: A pilot randomized, double-blind, controlled study","volume":"39","author":"Alvarenga","year":"2020","journal-title":"Clin. Nutr."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s11255-020-02760-z","article-title":"Can curcumin supplementation reduce plasma levels of gut-derived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study","volume":"53","author":"Salarolli","year":"2021","journal-title":"Int. Urol. Nephrol."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Pivari, F., Mingione, A., Piazzini, G., Ceccarani, C., Ottaviano, E., Brasacchio, C., Dei Cas, M., Vischi, M., Cozzolino, M.G., and Fogagnolo, P. (2022). Curcumin Supplementation (Meriva(\u00ae)) Modulates Inflammation, Lipid Peroxidation and Gut Microbiota Composition in Chronic Kidney Disease. Nutrients, 14.","DOI":"10.3390\/nu14010231"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"D\u2019Andurain, J., L\u00f3pez, V., Arazo-Rusindo, M., Tiscornia, C., Aicardi, V., Sim\u00f3n, L., and Mariotti-Celis, M.S. (2023). Effect of Curcumin Consumption on Inflammation and Oxidative Stress in Patients on Hemodialysis: A Literature Review. Nutrients, 15.","DOI":"10.3390\/nu15102239"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.biochi.2023.05.001","article-title":"Effects of resveratrol on inflammation and oxidative stress induced by the uremic toxin indoxyl sulfate in Murine macrophage-like RAW 264.7","volume":"213","author":"Alvarenga","year":"2023","journal-title":"Biochimie"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"301982","DOI":"10.1155\/2013\/301982","article-title":"Oxidative stress and nucleic acid oxidation in patients with chronic kidney disease","volume":"2013","author":"Sung","year":"2013","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(00)02783-5","article-title":"Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial","volume":"356","author":"Boaz","year":"2000","journal-title":"Lancet"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.CIR.0000050628.11305.30","article-title":"The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: A randomized, controlled trial","volume":"107","author":"Tepel","year":"2003","journal-title":"Circulation"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1523-1755.2004.00809.x","article-title":"Protective effect of vitamin C on 8-hydroxy-2\u2032-deoxyguanosine level in peripheral blood lymphocytes of chronic hemodialysis patients","volume":"66","author":"Tarng","year":"2004","journal-title":"Kidney Int."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Tsai, L.T., Weng, T.I., Chang, T.Y., Lan, K.C., Chiang, C.K., and Liu, S.H. (2023). Inhibition of Indoxyl Sulfate-Induced Reactive Oxygen Species-Related Ferroptosis Alleviates Renal Cell Injury In Vitro and Chronic Kidney Disease Progression In Vivo. Antioxidants, 12.","DOI":"10.3390\/antiox12111931"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"118807","DOI":"10.1016\/j.lfs.2020.118807","article-title":"Indoxyl sulfate induces ROS production via the aryl hydrocarbon receptor-NADPH oxidase pathway and inactivates NO in vascular tissues","volume":"265","author":"Nakagawa","year":"2021","journal-title":"Life Sci."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Duval-Sabatier, A., Burtey, S., Pelletier, M., Laforet, M., Dou, L., Sallee, M., Lorec, A.M., Knidiri, H., Darbon, F., and Berland, Y. (2023). Systematic Comparison of Uremic Toxin Removal Using Different Hemodialysis Modes: A Single-Center Crossover Prospective Observational Study. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020373"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/hdi.12924","article-title":"Effect of a medium cut-off dialyzer on protein-bound uremic toxins and mineral metabolism markers in patients on hemodialysis","volume":"25","author":"Tiong","year":"2021","journal-title":"Hemodial. Int. Int. Symp. Home Hemodial."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.kint.2016.11.002","article-title":"Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial","volume":"91","author":"Sirich","year":"2017","journal-title":"Kidney Int."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000500014","article-title":"Adsorption of Protein-Bound Uremic Toxins Using Activated Carbon through Direct Hemoperfusion in vitro","volume":"48","author":"Yamamoto","year":"2019","journal-title":"Blood Purif."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/aor.12961","article-title":"Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion with Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis","volume":"42","author":"Yamamoto","year":"2018","journal-title":"Artif. Organs"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000478971","article-title":"Vitamin E-Coated Dialyzer Inhibits Oxidative Stress","volume":"44","author":"Yamadera","year":"2017","journal-title":"Blood Purif."},{"key":"ref_156","first-page":"5","article-title":"Effects of dialysis purity on uremic dyslipidemia","volume":"14","author":"Schiffl","year":"2010","journal-title":"Ther. Apher. Dial. Off. Peer-Rev. J. Int. Soc. Apher. Jpn. Soc. Apher. Jpn. Soc. Dial. Ther."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s40620-022-01283-3","article-title":"High-volume hemodiafiltration decreases the pre-dialysis concentrations of indoxyl sulfate and p-cresyl sulfate compared to hemodialysis: A post-hoc analysis from the HDFit randomized controlled trial","volume":"35","author":"Lima","year":"2022","journal-title":"J. Nephrol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2215\/CJN.05240418","article-title":"Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor","volume":"14","author":"Madero","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Yamamoto, S., Sasahara, K., Domon, M., Yamaguchi, K., Ito, T., Goto, S., Goto, Y., and Narita, I. (2021). pH-Dependent Protein Binding Properties of Uremic Toxins In Vitro. Toxins, 13.","DOI":"10.3390\/toxins13020116"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.25122\/jml-2023-0128","article-title":"Protective effect of activated charcoal against progression of chronic kidney disease: A randomized clinical study","volume":"16","author":"Rahman","year":"2023","journal-title":"J. Med. Life"},{"key":"ref_161","first-page":"105","article-title":"Oral sorbent suppresses accumulation of albumin-bound indoxyl sulphate in serum of haemodialysis patients","volume":"6","author":"Niwa","year":"1991","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc.-Eur. Ren. Assoc."},{"key":"ref_162","first-page":"2491","article-title":"Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice","volume":"26","author":"Yamamoto","year":"2011","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc.-Eur. Ren. Assoc."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"68","DOI":"10.23876\/j.krcp.2017.36.1.68","article-title":"Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: Post-hoc analysis of the Kremezin Study against renal disease progression in Korea","volume":"36","author":"Cha","year":"2017","journal-title":"Kidney Res. Clin. Pract."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"14381","DOI":"10.1038\/srep14381","article-title":"Continuous Reduction of Protein-Bound Uraemic Toxins with Improved Oxidative Stress by Using the Oral Charcoal Adsorbent AST-120 in Haemodialysis Patients","volume":"5","author":"Yamamoto","year":"2015","journal-title":"Sci. Rep."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/16\/6\/254\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:51:31Z","timestamp":1760107891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/16\/6\/254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":164,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["toxins16060254"],"URL":"https:\/\/doi.org\/10.3390\/toxins16060254","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,31]]}}}